Your browser doesn't support javascript.
loading
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Bonet, Marta; González, David; Baquedano, José-Enrique; García, Elena; Altabas, Manuel; Casas, Francesc; Feltes, Nicolás; Ferrer, Ferran; Foro, Palmira; Fuentes, Rafael; Galdeano, Manuel; Gomez, David; Henriquez, Ivan; Jové, Josep; Lozano, Joan; Maldonado, Xavier; Mases, Joel; Membrive, Ismael; Paredes, Saturio; Roselló, Àlvar; Sancho, Gemma; Mira, Moisés.
Afiliação
  • Bonet M; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. Mabonet.lleida.ics@gencat.cat.
  • González D; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Baquedano JE; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • García E; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Altabas M; Radiation Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Casas F; Radiation Oncology, Hospital Clínic, ICMHO (Institut Clínic de Malalties Hematològiques i Oncològiques), Barcelona, Spain.
  • Feltes N; Radiation Oncology, Consorci Sanitari de Terrassa, Hospital de Terrassa, Terrassa, Spain.
  • Ferrer F; Radiation Oncology, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.
  • Foro P; Radiation Oncology, Parc de Salut Mar, Barcelona, Spain.
  • Fuentes R; Radiation Oncology, Institut Català d'Oncologia, Hospital Josep Trueta, Barcelona, Spain.
  • Galdeano M; Radiation Oncology, Consorci Sanitari de Terrassa, Fundació Althaia, Manresa, Spain.
  • Gomez D; Radiation Oncology, Hospital Sant Joan de Reus, Reus, Tarragona, Spain.
  • Henriquez I; Radiation Oncology, Hospital Sant Joan de Reus, Reus, Tarragona, Spain.
  • Jové J; Radiation Oncology, Institut Català d'Oncologia, Hospital Can Ruti, Badalona, Spain.
  • Lozano J; Radiation Oncology, Consorci Sanitari de Terrassa, Hospital de Terrassa, Terrassa, Spain.
  • Maldonado X; Radiation Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Mases J; Radiation Oncology, Hospital Clínic, ICMHO (Institut Clínic de Malalties Hematològiques i Oncològiques), Barcelona, Spain.
  • Membrive I; Radiation Oncology, Parc de Salut Mar, Barcelona, Spain.
  • Paredes S; Radiation Oncology, Consorci Sanitari de Terrassa, Fundació Althaia, Manresa, Spain.
  • Roselló À; Radiation Oncology, Institut Català d'Oncologia, Hospital Josep Trueta, Barcelona, Spain.
  • Sancho G; Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Mira M; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Clin Transl Oncol ; 25(4): 1017-1023, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36436177
ABSTRACT

BACKGROUND:

To reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of Radiation Oncologists in Catalonia dedicated to prostate cancer.

METHODS:

A modified Delphi approach was employed to reach consensus on controversial topics in Radiation Oncology on high-risk non-metastatic (eight questions) and post-operative (eight questions) prostate cancer. An agreement of at least 75% was considered as consensus. The survey was electronically sent 6 weeks before an expert meeting where topics were reviewed and discussed. A second-round survey for the controversial questions only was sent and answered by participants after the meeting.

RESULTS:

After the first round of the survey, 19 experienced Radiation Oncologists attended the meeting and 74% fulfilled the second-round online questionnaire. An agreement of 9 of the 16 questions was accounted for the first round. After the meeting, an additional agreement was reached in 3 questions leading to a final consensus on 12 of the 16 questions. There are still controversial topics like the use of PET for staging of high-risk and post-operative non-metastatic prostate cancer and the optimal dose to the prostate bed in the salvage setting.

CONCLUSION:

This consensus contributes to establish recommendations and a framework to help in prostate cancer radiation therapy and pharmacological management in daily clinical practice of high-risk and post-operative non-metastatic prostate cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Europa Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Europa Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha